Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy

PURPOSE: To compare the effectiveness of intravitreal injections of bevacizumab and ranibizumab in patients with treatment-naive polypoidal choroidal vasculopathy (PCV). METHODS: Records from 106 consecutive patients who received intraviteral bevacizumab (n = 58, 1.25 mg) or ranibizumab (n = 52, 0.5...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Han Joo, Baek, Ji Seon, Lee, Dong Won, Kim, Chul Gu, Kim, Jong Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364425/
https://www.ncbi.nlm.nih.gov/pubmed/22670070
http://dx.doi.org/10.3341/kjo.2012.26.3.157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364425/
https://www.ncbi.nlm.nih.gov/pubmed/22670070
http://dx.doi.org/10.3341/kjo.2012.26.3.157

Ejemplares similares